Jordi Ordonez-Llanos
Overview
Explore the profile of Jordi Ordonez-Llanos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
140
Citations
2249
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ordonez-Llanos J, Escola-Gil J
Int J Mol Sci
. 2024 Jul;
25(13).
PMID: 39000153
Although apolipoproteins (apo) were initially acknowledged as major determinants in lipoprotein metabolism and cardiovascular disease, the findings of recent studies have revealed the significance of multiple apolipoprotein classes and subclasses...
2.
Popova E, Paniagua-Iglesias P, Alvarez-Garcia J, Vives-Borras M, Gonzalez-Osuna A, Garcia-Osuna A, et al.
J Clin Med
. 2023 Aug;
12(16).
PMID: 37629413
Perioperative myocardial injury (PMI) is a common cardiac complication. Recent guidelines recommend its systematic screening using high-sensitivity cardiac troponin (hs-cTn). However, there is limited evidence of local screening programs. We...
3.
Enriquez-Vazquez D, Quintanilla J, Garcia-Escolano A, Couselo-Seijas M, Simon-Chica A, Lee P, et al.
Nat Commun
. 2023 Aug;
14(1):4613.
PMID: 37542075
Electromechanical characterization during atrial fibrillation (AF) remains a significant gap in the understanding of AF-related atrial myopathy. This study reports mechanistic insights into the electromechanical remodeling process associated with AF...
4.
Jaffe A, Body R, Mills N, Aakre K, Collinson P, Saenger A, et al.
J Am Coll Cardiol
. 2023 Jun;
82(1):60-69.
PMID: 37380305
The term "single-sample rule-out" refers to the ability of very low concentrations of high-sensitivity cardiac troponin (hs-cTn) on presentation to exclude acute myocardial infarction with high clinical sensitivity and negative...
5.
Hammarsten O, Warner J, Lam L, Kavsak P, Lindahl B, Aakre K, et al.
Clin Chem Lab Med
. 2023 Mar;
61(8):1411-1419.
PMID: 36952681
The International Federation of Clinical Chemistry Committee on Clinical Applications of Cardiac Biomarkers (IFCC C-CB) provides educational documents to facilitate the interpretation and use of cardiac biomarkers in clinical laboratories...
6.
Alvarez-Garcia J, Popova E, Vives-Borras M, de Nadal M, Ordonez-Llanos J, Rivas-Lasarte M, et al.
BMC Cardiovasc Disord
. 2023 Feb;
23(1):78.
PMID: 36765313
Background: Myocardial injury after non-cardiac surgery (MINS) is a frequent complication caused by cardiac and non-cardiac pathophysiological mechanisms, but often it is subclinical. MINS is associated with increased morbidity and...
7.
Popova E, Alonso-Coello P, Alvarez-Garcia J, Paniagua-Iglesias P, Rue-Monne M, Vives-Borras M, et al.
Eur J Anaesthesiol
. 2023 Feb;
40(3):179-189.
PMID: 36722187
Background: About 300 million surgeries are performed worldwide annually and this figure is increasing constantly. Peri-operative myocardial injury (PMI), detected by cardiac troponin (cTn) elevation, is a common cardiac complication...
8.
Caravaca Perez P, Gonzalez-Juanatey J, Nuche J, Matute-Blanco L, Serrano I, Martinez Selles M, et al.
Front Cardiovasc Med
. 2022 Apr;
9:861651.
PMID: 35463785
Introduction: Galectin-3 (Gal-3) is an inflammatory marker associated with the development and progression of heart failure (HF). A close relationship between Gal-3 levels and renal function has been observed, but...
9.
Saumoy M, Sanchez-Quesada J, Assoumou L, Gatell J, Gonzalez-Cordon A, Guaraldi G, et al.
J Antimicrob Chemother
. 2022 Apr;
77(7):1980-1988.
PMID: 35411401
Background: The aim of this study was to investigate whether switching from a ritonavir-boosted PI-based regimen to a dolutegravir-based regimen improved the atherogenic properties of LDL particles in patients with...
10.
Garcia-Osuna A, Sans-Rosello J, Ferrero-Gregori A, Alquezar-Arbe A, Sionis A, Ordonez-Llanos J
J Clin Med
. 2022 Mar;
11(5).
PMID: 35268358
Introduction: Myocardial infarction with ST-segment elevation (STEMI) is the coronary artery disease associated with the highest risk of morbimortality; however, this risk is heterogeneous, usually being evaluated by clinical scores....